Comments on: AstraZeneca divests Atacand’s European rights for $210m /news/astrazeneca-atacands-european-rights/ The leading site for news and procurement in the pharmaceutical industry Fri, 27 Jul 2018 03:29:59 +0000 hourly 1 https://wordpress.org/?v=6.6.2